How re-engineering antibodies can prevent allergies
The California startup IgGenix is aiming to re-engineer antibodies that mediate allergic responses into antibodies…
August 19, 2022 - 9 minutes
Allergy
Find all the latest worldwide news and in-depth articles related to allergies. This section includes the latest research, regulations, collaboration deals, and technology advancements of allergy immunotherapy companies.
From mugwort allergy to an effective vaccine?
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…
June 22, 2022 - 2 minutes
DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
April 14, 2021 - 5 minutes
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
May 8, 2019 - 7 minutes
Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
March 18, 2019 - 2 minutes
Inflammatory Disease Treatment Backed by €20M Series A
The Swiss company Calypso Biotech has raised a sizeable €20M to fund its immunotherapy for…
February 20, 2019 - 2 minutes
This Hypoallergenic Vaccine Could Alleviate Hay Fever Faster Than Approved Vaccines
We decided to make a visit to Espoo, Finland, this week, to visit Desentum. The…
December 7, 2018 - 4 minutes
This Immunotherapy Could Be The First to Treat Milk Allergy in Children
DBV Technologies has shown in a Phase II trial that its skin patch could desensitize…
May 29, 2018 - 2 minutes
Positive House Dust Mite Immunotherapy Results for UK Biotech
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
May 29, 2018 - 1 minute
Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
May 23, 2018 - 2 minutes
DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial
DBV Technologies' candidate could be the first treatment for allergies to cow milk after its…
February 27, 2018 - 3 minutes
ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies
ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to…
February 26, 2018 - 3 minutes
